Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation

• Published in: Ageing research reviews Vol. 72; p. 101462
• Main Authors: Tournissac, Marine, Leclerc, Manon, Valentin-Escalera, Josue, Vandal, Milène, Bosoi, Cristina R., Planel, Emmanuel, Calon, Frédéric
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01.12.2021
• Subjects: Adipose Tissue, Brown - metabolism; Aged; Alzheimer Disease - metabolism; Alzheimer’s disease; Body temperature; Body Temperature Regulation; Brown adipose tissue; Energy Metabolism; Humans; Insulin; Metabolism; Neurodegenerative Diseases - metabolism; Thermogenesis; Thermoregulation; β-adrenergic agonist; FDG-PET; BBB; UCP1; Thermoregulation; CNS; Brown adipose tissue; Aβ; GSK-3β; β-adrenergic agonist; MMSE; CSF; APOE; TRPM8; β3AR; NFT; FGF21; AD; GLP-1; Alzheimer’s disease; SGLT2; Body temperature; T2D; 3xTg-AD; PP2A; Metabolism; Insulin; MCI; APN-EPC; BAT; TZD
• ISSN: 1568-1637; 1872-9649
• DOI: 10.1016/j.arr.2021.101462

Alzheimer’s disease (AD) is a complex age-related neurodegenerative disease, associated with central and peripheral metabolic anomalies, such as impaired glucose utilization and insulin resistance. These observations led to a considerable interest not only in lifestyle-related interventions, but also in repurposing insulin and other anti-diabetic drugs to prevent or treat dementia. Body temperature is the oldest known metabolic readout and mechanisms underlying its maintenance fail in the elderly, when the incidence of AD rises. This raises the possibility that an age-associated thermoregulatory deficit contributes to energy failure underlying AD pathogenesis. Brown adipose tissue (BAT) plays a central role in thermogenesis and maintenance of body temperature. In recent years, the modulation of BAT activity has been increasingly demonstrated to regulate energy expenditure, insulin sensitivity and glucose utilization, which could also provide benefits for AD. Here, we review the evidence linking thermoregulation, BAT and insulin-related metabolic defects with AD, and we propose mechanisms through which correcting thermoregulatory impairments could slow the progression and delay the onset of AD. •The main risk factor of AD, old age, is also associated with metabolic failures, including thermoregulatory deficits.•Evidence suggest that age-associated thermoregulatory deficit contributes to energy failure underlying AD pathogenesis.•Brown adipose tissue (BAT) plays a central role in thermogenesis and maintenance of body temperature.•Correcting thermoregulation defects in the elderly may counteract early AD triggering events.